Combined Flt3L/TK Gene Therapy Induces Immunological Surveillance Which Mediates an Immune Response Against a Surrogate Brain Tumor Neoantigen

This publication has 51 references indexed in Scilit:

• Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
  Neuro-Oncology, 2010
• Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology
  Proceedings of the National Academy of Sciences, 2010
• Adoptive T cell therapy of cancer
  Current Opinion in Immunology, 2010
• Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
  Neuro-Oncology, 2010
• Gene Transfer into Rat Brain Using Adenoviral Vectors
  Current Protocols in Neuroscience, 2010
• Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
  Cancer Cell, 2010
• Gene Transfer into Neural Cells In Vitro Using Adenoviral Vectors
  Current Protocols in Neuroscience, 2008
• Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
  Seminars in Immunology, 2008
• Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain
  Cancer Immunology, Immunotherapy, 2008
• Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
  New England Journal of Medicine, 2005